CSG’s Explosive Q1 Profit and €44bn Pipeline Face a Stubborn 44% Stock Discount

CSG Q1 profit surged 83% to €299m, order pipeline €44bn, but short-seller dispute and weak ammo margins keep stock at €18.97. Analysts see 70% upside.

The Czechoslovak Group (CSG) delivered a blockbuster first quarterly report since its January IPO, but the stock still trades at a yawning discount to both its peak and the price target implied by analysts. While net profit more than doubled and the order pipeline swells to €44bn, a lingering short-seller dispute and weak margins in the small-calibre ammunition segment have kept investors cautious.

For the quarter ended March, CSG posted revenue of €1.544bn, up 13.8% from a year earlier. Net profit surged 83% to €299m, powered by the Defence Systems division. That unit alone generated €1.251bn in sales — a 26.5% jump — and an operating EBIT margin of 28.4%. The company’s total order backlog climbed 15% to €17bn, with a further €27bn in the negotiation pipeline, signalling sustained demand for large-calibre munitions and military hardware.

Yet the Ammo+ segment, which focuses on small-arms ammunition, proved a drag. Revenue there came in at €291m and the operating margin slumped to just 4.3%, hurt by weakness in the US commercial channel and heavy investment in new production capacity. Management says demand rebounded sharply from the end of March, and higher prices are supporting a recovery. The company is expanding its 5.56mm output to serve additional contracts with US law enforcement agencies and the FBI. Margin and revenue in the unit are expected to improve meaningfully over the rest of the year.

CSG reaffirmed its full-year outlook, targeting 2026 revenue between €7.4bn and €7.6bn and an operating EBIT margin of 24% to 25%. The defence sector’s tailwinds remain strong: NATO’s procurement push, a new €90bn EU credit facility for Ukraine, and Germany’s planned €3bn spending package on night-vision gear and air-defence systems all point to a buoyant order environment. The European defence index STOXX 600 recently hit a two-week high, reflecting the sector’s momentum.

None of that, however, has fully dispelled the cloud cast by Hunterbrook Media. In early May, the short-selling research firm accused CSG of refurbishing old ammunition rather than producing new rounds, and questioned the transparency of its IPO process. CSG issued two formal rebuttals, accusing Hunterbrook of cherry-picking public information to support a short position. The company disclosed that it manufactured roughly 630,000 rounds in 2025 and aims to boost that to 1.1 million over the medium term, with production spread across Slovakia, Greece, Serbia, Spain and India. An independent verification of those claims has not yet occurred, leaving the controversy unresolved.

Analysts, for now, are firmly on the bull side. All ten covering the stock rate it a buy, with an average price target of €32.85 — implying a 70% upside from current levels. The highest estimate stands at €42. The 52-week high of €33.81 was set in January at the time of the IPO; the stock now sits at around €18.97, roughly 44% below that peak. Following the Q1 release on May 20, the shares jumped more than 13%, and over the past week they have gained about 16%. Still, on a monthly basis the stock is down roughly 7%.

Credit-rating agencies have added to the positive signals. Moody’s upgraded CSG’s secured debt to Baa3, while Fitch affirmed its BBB- rating with a stable outlook. The next major catalyst will be the half-year results due in August. Until then, the gap between the company’s operational momentum and its market valuation — not to mention the unresolved Hunterbrook debate — will keep the investment case a contentious one.